Abstract
Research was carried out on 74 hemodialysis patients to determine the frequency of anti-HCV antibodies; this was done by means of the 1st and 2nd generation screening and control tests. The 1st generation tests showed 9 HCV-seropositive patients, while the 2nd generation tests demonstrated 15 HCV-seropositive patients. It seems evident that the 2nd generation tests are more sensitive than those of the 1st.
MeSH terms
-
Adult
-
Aged
-
Enzyme-Linked Immunosorbent Assay / methods
-
Enzyme-Linked Immunosorbent Assay / statistics & numerical data
-
Female
-
Hepacivirus / immunology*
-
Hepatitis Antibodies / blood*
-
Hepatitis C / diagnosis
-
Hepatitis C / immunology
-
Humans
-
Immunoassay / methods*
-
Immunoassay / statistics & numerical data
-
Immunoblotting / methods
-
Immunoblotting / statistics & numerical data
-
Male
-
Middle Aged
-
Renal Dialysis / adverse effects
-
Sensitivity and Specificity
-
Uremia / therapy